Mangoceuticals: Unregistered Sales Of Equity Securities, ), Which Information Is Incorporated Herein By Reference, The 2,554 Outstanding Shares Of Series B Convertible Preferred Stock (the “, Material Modification To Rights Of Security Holders, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, The Second Amendment Was Originally Approved By The Board Of Directors Of The Company On February 15, 2025, Subject To Stockholder Approval And The Second Amendment Became Effective At The Time Of Stockholder Approval, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Mangoceuticals Inc
• Registration country
  USA
• Industry
  Miscellaneous Healthcare: Products and Services
• М/S&P/F
  *** / *** / ***